NTRK2 and central nervous system cancer: Moreover, they compared the effects of NLGN3 and BDNF on glioma, reporting that while NLGN3 upregulates the expression of AMPAR subunits, BDNF-TrKB signaling promotes AMPAR subunit trafficking to the glioma cell membrane [87].